
PRVA Stock Forecast & Price Target
PRVA Analyst Ratings
Bulls say
Privia Health Group Inc. has demonstrated significant growth, achieving the addition of 125 providers in the fourth quarter of 2025, with strong expectations for ongoing performance due to favorable trends in the Arizona market. The company reported a sequential increase of approximately 9% in practice collections per provider, translating to about $80 million, driven by record profitability from its capitation and value-based care segments. Enhanced operational efficiencies and a robust pipeline of new providers and visit volumes are expected to sustain the firm's positive momentum into future fiscal periods.
Bears say
Privia Health Group Inc faces significant challenges due to anticipated declines in Medicaid enrollment, specifically an expected 8%-10% decrease in membership stemming from re-determination activities post-public health emergency. The company's guidance indicates a sequential decline in EBITDA, following a strong Q3, suggesting potential weakness in profitability. Additionally, the expectation for a 2% quarter-over-quarter decline in a period generally characterized by seasonal growth further underscores the company's vulnerable position in the current market environment.
This aggregate rating is based on analysts' research of Privia Health Group and is not a guaranteed prediction by Public.com or investment advice.
PRVA Analyst Forecast & Price Prediction
Start investing in PRVA
Order type
Buy in
Order amount
Est. shares
0 shares